Industry 4.0: What is the Future Role of Process Analytical Tools (PATs)?
Wednesday, May 29, 2024 09:15 AM - 10:15 AM
Room 208-209
Roundtable
Organized by: ISCT Process Development & Manufacturing Subcommittee
Moderator
Key Learning Objectives
1. Lessons learned from real life example (discovery to PD to mfg deployment of Raman spectroscopy for AAV) – how can this then be more broadly exploited beyond CGTC?
2. How to build PAT deployment and next generation bioprocessing as part of the company strategy.
3. Using these two differentiating elements to increase asset/company valuation. Is this possible?
Moderator
- Fernanda Masri, PhD, Cytomos, United Kingdom
- Jason Foster, MBA, Ori Biotech, United Kingdom
- Phil Vanek, PhD, Gamma Biosciences, United States
- Stephen Ward, PhD, Cell and Gene Therapy Catapult, United Kingdom
Key Learning Objectives
1. Lessons learned from real life example (discovery to PD to mfg deployment of Raman spectroscopy for AAV) – how can this then be more broadly exploited beyond CGTC?
2. How to build PAT deployment and next generation bioprocessing as part of the company strategy.
3. Using these two differentiating elements to increase asset/company valuation. Is this possible?
